Association of Existence of Sarcopenia and Poor Recovery of Swallowing Function in Post-Stroke Patients with Severe Deglutition Disorder: A Multicenter Cohort Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
03 Oct 2022
Historique:
received: 26 07 2022
revised: 26 09 2022
accepted: 29 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

The effect of sarcopenia on the recovery of swallowing function, and the interaction among sarcopenia, nutrition care, and rehabilitation therapy are inconclusive. This multicenter cohort study was conducted between November 2018 and October 2020 in convalescent rehabilitation hospitals in Japan and included post-stroke patients aged ≥65 years with dysphagia. All participants were assigned to sarcopenia and non-sarcopenia groups. The primary outcome was the achievement of ≥2 Food Intake Level Scale [FILS] gain, and the secondary outcomes included Functional Independence Measure (FIM) gain and efficiency. Considering the effect modification of energy intake and rehabilitation duration, logistic regression analyses were performed. Overall, 153 participants with (median age, 82 years; 57.5% women) and 40 without (median age 75 years; 35.0% women) sarcopenia were included. The non-sarcopenia group had more patients who achieved an FILS gain of ≥2 (75.0%) than the sarcopenia group (51.0%). Sarcopenia was independently associated with a poor FILS gain (odds ratio:0.34, 95% confidence intervals: 0.13-0.86) but not associated with FIM gain or efficiency. This association was not affected by the rehabilitation duration or energy intake. In conclusion, sarcopenia was negatively associated with the recovery of swallowing function in stroke patients without interaction by energy intake and rehabilitation duration.

Sections du résumé

BACKGROUND BACKGROUND
The effect of sarcopenia on the recovery of swallowing function, and the interaction among sarcopenia, nutrition care, and rehabilitation therapy are inconclusive.
METHODS METHODS
This multicenter cohort study was conducted between November 2018 and October 2020 in convalescent rehabilitation hospitals in Japan and included post-stroke patients aged ≥65 years with dysphagia. All participants were assigned to sarcopenia and non-sarcopenia groups. The primary outcome was the achievement of ≥2 Food Intake Level Scale [FILS] gain, and the secondary outcomes included Functional Independence Measure (FIM) gain and efficiency. Considering the effect modification of energy intake and rehabilitation duration, logistic regression analyses were performed.
RESULTS RESULTS
Overall, 153 participants with (median age, 82 years; 57.5% women) and 40 without (median age 75 years; 35.0% women) sarcopenia were included. The non-sarcopenia group had more patients who achieved an FILS gain of ≥2 (75.0%) than the sarcopenia group (51.0%). Sarcopenia was independently associated with a poor FILS gain (odds ratio:0.34, 95% confidence intervals: 0.13-0.86) but not associated with FIM gain or efficiency. This association was not affected by the rehabilitation duration or energy intake.
CONCLUSIONS CONCLUSIONS
In conclusion, sarcopenia was negatively associated with the recovery of swallowing function in stroke patients without interaction by energy intake and rehabilitation duration.

Identifiants

pubmed: 36235767
pii: nu14194115
doi: 10.3390/nu14194115
pmc: PMC9571320
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nagasaki Rehabilitation Hospital
ID : There was no grant number

Références

J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
Nutrients. 2021 Feb 11;13(2):
pubmed: 33670314
Nutr Clin Pract. 2021 Aug;36(4):828-832
pubmed: 34161626
J Nutr Health Aging. 2018;22(8):1003-1009
pubmed: 30272106
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
Eur Geriatr Med. 2020 Apr;11(2):333-340
pubmed: 32297201
Nat Rev Gastroenterol Hepatol. 2015 May;12(5):259-70
pubmed: 25850008
Clin Nutr. 2018 Feb;37(1):204-207
pubmed: 28017450
Arch Phys Med Rehabil. 1998 Mar;79(3):329-35
pubmed: 9523787
Nutrition. 2019 May;61:111-118
pubmed: 30710883
J Pain Symptom Manage. 2013 Aug;46(2):201-6
pubmed: 23159683
Dysphagia. 2021 Jun;36(3):523-531
pubmed: 33620563
Neurorehabil Neural Repair. 2011 Jul-Aug;25(6):540-7
pubmed: 21451116
Dysphagia. 2016 Jun;31(3):434-41
pubmed: 26970760
Clin Nutr. 2017 Aug;36(4):1089-1096
pubmed: 27426415
Dysphagia. 2015 Feb;30(1):80-7
pubmed: 25248988
Geriatr Gerontol Int. 2019 Feb;19(2):91-97
pubmed: 30628181
J Am Med Dir Assoc. 2018 Jun;19(6):516-522
pubmed: 29287693
Cochrane Database Syst Rev. 2018 Oct 30;10:CD000323
pubmed: 30376602
J Am Med Dir Assoc. 2019 May;20(5):564-568
pubmed: 30852165
J Am Med Dir Assoc. 2015 Apr;16(4):272-6
pubmed: 25676847
Arch Gerontol Geriatr. 2021 Sep-Oct;96:104439
pubmed: 34090127
Nutr Diet. 2020 Sep;77(4):456-466
pubmed: 31499583
Am J Phys Med Rehabil. 2016 Jun;95(6):e84-9
pubmed: 26829095
J Stroke Cerebrovasc Dis. 2019 May;28(5):1381-1387
pubmed: 30857927
J Acad Nutr Diet. 2016 Apr;116(4):573-7
pubmed: 26549542
Arch Phys Med Rehabil. 1996 Dec;77(12):1226-32
pubmed: 8976303
Arch Gerontol Geriatr. 2020 Jul - Aug;89:104109
pubmed: 32460125
Phys Ther. 1966 Apr;46(4):357-75
pubmed: 5907254
J Am Geriatr Soc. 2012 Sep;60(9):1785-6
pubmed: 22985156
Clin Nutr. 2020 Sep;39(9):2786-2792
pubmed: 31866129
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):351-7
pubmed: 26673551
J Am Med Dir Assoc. 2021 Dec;22(12):2527-2533.e1
pubmed: 34389335
Lancet. 2011 Sep 24;378(9797):1183-92
pubmed: 21885099
Geriatr Gerontol Int. 2019 Nov;19(11):1124-1128
pubmed: 31591820
Healthcare (Basel). 2021 Jun 18;9(6):
pubmed: 34207324
Eur J Neurol. 2020 Oct;27(10):2014-2021
pubmed: 32515514
J Clin Neurosci. 2020 Jan;71:113-118
pubmed: 31495657

Auteurs

Shinta Nishioka (S)

Department of Clinical Nutrition and Food Service, Nagasaki Rehabilitation Hospital, Nagasaki 850-0854, Japan.

Ichiro Fujishima (I)

Department of Rehabilitation Medicine, Hamamatsu City Rehabilitation Hospital, Hamamatsu 433-8511, Japan.

Masako Kishima (M)

Department of Dentistry, Wakakusa-Tatsuma Rehabilitation Hospital, Daito 574-0012, Japan.

Tomohisa Ohno (T)

Department of Dentistry, Hamamatsu City Rehabilitation Hospital, Hamamatsu 433-8511, Japan.

Akio Shimizu (A)

Department of Health Science, Faculty of Health and Human Development, University of Nagano, Miwa 380-8525, Japan.

Takashi Shigematsu (T)

Department of Rehabilitation Medicine, Hamamatsu City Rehabilitation Hospital, Hamamatsu 433-8511, Japan.

Masataka Itoda (M)

Department of Oral Rehabilitation, Osaka Dental University Hospital, Hirakata 573-1144, Japan.

Hidetaka Wakabayashi (H)

Department of Rehabilitation Medicine, Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo 162-0054, Japan.

Kenjiro Kunieda (K)

Department of Rehabilitation Medicine, Hamamatsu City Rehabilitation Hospital, Hamamatsu 433-8511, Japan.
Department of Neurology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Fumiko Oshima (F)

Department of Rehabilitation Medicine, Japanese Red Cross Society Suwa Hospital, Suwa 392-8510, Japan.

Sumito Ogawa (S)

Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan.

Kazuki Fukuma (K)

Department of Neurology, National Cerebral and Cardiovascular Center, Suita 564-8565, Japan.

Nami Ogawa (N)

Department of Dentistry, Sakaue Dental Office, Setagaya-ku, Tokyo 158-0094, Japan.

Jun Kayashita (J)

Department of Health Sciences, Prefectural University of Hiroshima, Hiroshima 734-8558, Japan.

Minoru Yamada (M)

Faculty of Human Sciences, University of Tsukuba, Bunkyo-ku, Tokyo 112-0012, Japan.

Takashi Mori (T)

Department of Oral and Maxillofacial Surgery, Southern Tohoku General Hospital, Koriyama 963-8563, Japan.

Shinya Onizuka (S)

Department of Rehabilitation Medicine, Nagasaki Rehabilitation Hospital, Nagasaki 850-0854, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH